Maintelyte

Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, and Sodium Acetate Trihydrate, the active ingredients in Maintelyte, are an electrolyte solution presented as an injection solution for intravenous use. It provides rapid fluid and electrolyte replenishment for patients with electrolyte imbalances such as hypomagnesemia, hypokalemia, hyponatremia, or those requiring fluid resuscitation after surgery or trauma.

GNH USA supplies Maintelyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Maintelyte is used to correct electrolyte disturbances and support intravascular volume in clinical settings.

- Electrolyte replacement: restores normal concentrations of magnesium, potassium, sodium and chloride in patients with deficits. - Fluid resuscitation: expands intravascular volume in hypovolemic or dehydrated patients. - Hypomagnesemia: corrects low serum magnesium levels. - Hypokalemia: corrects low serum potassium levels. - Hyponatremia: corrects low serum sodium levels.

Maintelyte may be associated with infusion‑related reactions and electrolyte‑related adverse events.

Common Side Effects: - Infusion site pain or irritation. - Mild hypernatremia. - Mild hyperkalemia. - Transient fluid overload.

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hypermagnesemia). - Anaphylactic or severe hypersensitivity reaction. - Cardiac arrhythmia due to rapid electrolyte shifts.

When using Maintelyte, clinicians should observe several safety measures to minimize risks.

- Baseline assessment: evaluate serum electrolyte levels before initiation. - Cardiac monitoring: observe rhythm during infusion, especially in patients with cardiac disease. - Renal function: adjust infusion rate in renal impairment to avoid accumulation. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Maintelyte can interact with other medications that affect electrolyte balance or renal function.

Major Interactions (Avoid): - Concurrent IV electrolyte solutions: risk of overload. - Loop diuretics: may exacerbate electrolyte shifts. - ACE inhibitors: increase potassium retention. - Digoxin: altered potassium levels affect toxicity.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: monitor cardiac rhythm. - NSAIDs: may impair renal clearance of electrolytes. - Beta‑blockers: observe blood pressure changes.